CHA AI Healthkare Co.,Ltd.

As of June 30, 2026, CHA AI Healthkare Co.,Ltd. carries a market capitalization of 128.99B, placing it among publicly traded companies globally. Its enterprise value stands at 154.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, CHA AI Healthkare Co.,Ltd. has 18.19M shares outstanding.

As of June 30, 2026, CHA AI Healthkare Co.,Ltd. trades at a trailing price-to-earnings ratio of 13.62. The price-to-sales ratio is 13.15, and the price-to-book ratio stands at 1.59.

These figures are as of June 30, 2026. The EV/Sales ratio of 18.31 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 154.47B versus a market cap of 128.99B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, CHA AI Healthkare Co.,Ltd. maintains a current ratio of 0.58, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 50.29, indicating elevated leverage, while an interest coverage ratio of -2.19 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, CHA AI Healthkare Co.,Ltd. posted a return on equity (ROE) of 13.48, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 9.43, measuring how efficiently the asset base is converted into earnings. The company generates approximately 188.49M in revenue per employee across its workforce of 44.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.13 indicates how many times CHA AI Healthkare Co.,Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, CHA AI Healthkare Co.,Ltd. recorded an income tax benefit of -2.02M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 8.16B, leaving 8.14B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, CHA AI Healthkare Co.,Ltd.'s stock has declined approximately 61.72% over the past 52 weeks. The 50-day moving average sits at 5,021.30, while the 200-day moving average is 7,576.18.

Over the twelve months ended June 30, 2026, CHA AI Healthkare Co.,Ltd. generated 8.43B in revenue and converted that into 8.14B in net income, yielding earnings per share of 499.55. EBITDA reached -6.79B, while operating income came in at -6.97B.

As of June 30, 2026, CHA AI Healthkare Co.,Ltd. holds 15.26B in cash and equivalents against 40.74B in total debt, resulting in a net debt position of 29.23B. Total book value stands at 81.00B, with working capital of -16.79B providing operational flexibility.

CHA AI Healthkare Co.,Ltd. produced -6.01B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -119.54M in capital expenditures, free cash flow totaled -6.13B - equivalent to -391.47 per share.

Over the twelve months ended June 30, 2026, CHA AI Healthkare Co.,Ltd. posted a gross margin of 27.56, reflecting its pricing power and cost economics. The operating margin of -82.58 and net profit margin of 96.56 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -5.29: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -64.61, meaning CHA AI Healthkare Co.,Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

CHA AI Healthkare Co.,Ltd.'s most recent stock split took place on December 19, 2022 with a 20:1 split ratio.

As of June 30, 2026, CHA AI Healthkare Co.,Ltd. has an Altman Z-Score of 0.03, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.